| RS1553957829 |
MFSD8
|
Health Risk |
Likely pathogenic |
Neuronal ceroid lipofuscinosis 7, Neuronal ceroid lipofuscinosis 7 |
| RS1553957856 |
MMAA
|
Health Risk |
Likely pathogenic |
Methylmalonic aciduria, cblA type |
| RS1553957862 |
MMAA
|
Health Risk |
Likely pathogenic |
Methylmalonic aciduria, cblA type |
| RS1553957883 |
MMAA
|
Health Risk |
Pathogenic/Likely pathogenic |
Methylmalonic aciduria, cblA type |
| RS1553957901 |
MMAA
|
Health Risk |
Likely pathogenic |
Methylmalonic aciduria, cblA type |
| RS1553957906 |
MMAA
|
Health Risk |
Pathogenic |
Methylmalonic aciduria, cblA type |
| RS1553957907 |
MMAA
|
Health Risk |
Pathogenic |
Methylmalonic aciduria, cblA type |
| RS1553957931 |
MMAA
|
Health Risk |
Pathogenic/Likely pathogenic |
Methylmalonic aciduria, cblA type |
| RS1553957938 |
MMAA
|
Health Risk |
Likely pathogenic |
Methylmalonic aciduria, cblA type |
| RS1553957939 |
MMAA
|
Health Risk |
Likely pathogenic |
Methylmalonic aciduria, cblA type |
| RS1553958126 |
MMAA
|
Health Risk |
Pathogenic |
Methylmalonic aciduria, cblA type |
| RS1553958127 |
MMAA
|
Health Risk |
Pathogenic |
Methylmalonic aciduria, cblA type |
| RS1553958143 |
MMAA
|
Health Risk |
Pathogenic |
— |
| RS1553958158 |
MMAA
|
Health Risk |
Pathogenic |
Methylmalonic aciduria, cblA type |
| RS1553958159 |
MMAA
|
Health Risk |
Pathogenic |
Methylmalonic aciduria, cblA type |
| RS1553958392 |
MMAA
|
Health Risk |
Pathogenic |
Methylmalonic aciduria, cblA type |
| RS1553958395 |
MMAA
|
Health Risk |
Likely pathogenic |
Methylmalonic aciduria, cblA type |
| RS1553958417 |
MMAA
|
Health Risk |
Pathogenic |
Methylmalonic aciduria, cblA type |
| RS1553958720 |
MMAA
|
Health Risk |
Likely pathogenic |
Methylmalonic aciduria, cblA type |
| RS1553959017 |
MMAA
|
Health Risk |
Pathogenic/Likely pathogenic |
Methylmalonic aciduria, cblA type |
| RS1553959024 |
MMAA
|
Health Risk |
Pathogenic |
Methylmalonic aciduria, cblA type |
| RS1553959025 |
MMAA
|
Health Risk |
Pathogenic |
Methylmalonic aciduria, cblA type |
| RS1553959113 |
MMAA
|
Health Risk |
Pathogenic |
Methylmalonic aciduria, cblA type |
| RS1553959152 |
MMAA
|
Health Risk |
Pathogenic |
Methylmalonic aciduria, cblA type |
| RS1553960137 |
FRAS1
|
Health Risk |
Likely pathogenic |
— |
| RS1553960776 |
ZEB2
|
Health Risk |
Pathogenic |
Mowat-Wilson syndrome, Mowat-Wilson syndrome |
| RS1553960778 |
ZEB2
|
Health Risk |
Pathogenic |
Mowat-Wilson syndrome, Mowat-Wilson syndrome |
| RS1553960788 |
ZEB2
|
Health Risk |
Likely pathogenic |
Mowat-Wilson syndrome, Mowat-Wilson syndrome |
| RS1553960793 |
ZEB2
|
Health Risk |
Pathogenic |
Mowat-Wilson syndrome, Mowat-Wilson syndrome |
| RS1553961332 |
ZEB2
|
Health Risk |
Likely pathogenic |
Mowat-Wilson syndrome, Mowat-Wilson syndrome |
| RS1553961343 |
ZEB2
|
Health Risk |
Pathogenic |
Mowat-Wilson syndrome, Mowat-Wilson syndrome |
| RS1553961487 |
ZEB2
|
Health Risk |
Pathogenic |
Mowat-Wilson syndrome, Mowat-Wilson syndrome |
| RS1553961510 |
ZEB2
|
Health Risk |
Pathogenic |
Mowat-Wilson syndrome, Mowat-Wilson syndrome |
| RS1553961516 |
ZEB2
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1553961536 |
ZEB2
|
Health Risk |
Conflicting classifications of pathogenicity |
Mowat-Wilson syndrome, Mowat-Wilson syndrome |
| RS1553961580 |
ZEB2
|
Health Risk |
Pathogenic |
Mowat-Wilson syndrome, Mowat-Wilson syndrome |
| RS1553961585 |
ZEB2
|
Health Risk |
Pathogenic |
Mowat-Wilson syndrome, Mowat-Wilson syndrome |
| RS1553961598 |
ZEB2
|
Health Risk |
Pathogenic |
Mowat-Wilson syndrome, Mowat-Wilson syndrome |
| RS1553961610 |
ZEB2
|
Health Risk |
Pathogenic |
Mowat-Wilson syndrome, Mowat-Wilson syndrome |
| RS1553961655 |
ZEB2
|
Health Risk |
Pathogenic |
— |
| RS1553961660 |
ZEB2
|
Health Risk |
Pathogenic |
— |
| RS1553961695 |
ZEB2
|
Health Risk |
Pathogenic |
Mowat-Wilson syndrome, Mowat-Wilson syndrome |
| RS1553961697 |
ZEB2
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1553961702 |
ZEB2
|
Health Risk |
Pathogenic |
Mowat-Wilson syndrome, Inborn genetic diseases |
| RS1553961705 |
ZEB2
|
Health Risk |
Pathogenic |
— |
| RS1553961746 |
ZEB2
|
Health Risk |
Pathogenic |
— |
| RS1553961747 |
ZEB2
|
Health Risk |
Likely pathogenic |
Mowat-Wilson syndrome, Mowat-Wilson syndrome |
| RS1553961749 |
ZEB2
|
Health Risk |
Pathogenic |
— |
| RS1553961777 |
ZEB2
|
Health Risk |
Pathogenic |
— |
| RS1553962048 |
ZEB2
|
Health Risk |
Pathogenic |
— |
| RS1553962069 |
ZEB2
|
Health Risk |
Pathogenic |
Mowat-Wilson syndrome, Mowat-Wilson syndrome |
| RS1553962198 |
ZEB2
|
Health Risk |
Pathogenic |
Mowat-Wilson syndrome, Mowat-Wilson syndrome |
| RS1553962493 |
NEB
|
Health Risk |
Likely pathogenic |
Nemaline myopathy 2, Nemaline myopathy 2 |
| RS1553963537 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS1553963960 |
NEB
|
Health Risk |
Pathogenic/Likely pathogenic |
Nemaline myopathy 2, Arthrogryposis multiplex congenita 6 |
| RS1553963973 |
NEB
|
Health Risk |
Likely pathogenic |
Nemaline myopathy 2, Nemaline myopathy 2 |
| RS1553964145 |
ZEB2
|
Health Risk |
Likely pathogenic |
Mowat-Wilson syndrome, Mowat-Wilson syndrome |
| RS1553964147 |
ZEB2
|
Health Risk |
Pathogenic |
Mowat-Wilson syndrome, Mowat-Wilson syndrome |
| RS1553964158 |
NEB
|
Health Risk |
Pathogenic |
Nemaline myopathy 2, Nemaline myopathy 2 |
| RS1553965518 |
FGG
|
Health Risk |
Likely pathogenic |
Inborn genetic diseases, Familial dysfibrinogenemia |
| RS1553965519 |
FGG
|
Health Risk |
Pathogenic |
Congenital afibrinogenemia, Congenital afibrinogenemia |
| RS1553965868 |
LRBA
|
Health Risk |
Likely pathogenic |
— |
| RS1553966356 |
NEB
|
Health Risk |
Conflicting classifications of pathogenicity |
Nemaline myopathy 2, Nemaline myopathy 2 |
| RS1553967481 |
SLC25A4
|
Health Risk |
Likely pathogenic |
— |
| RS1553969639 |
AFG2A
|
Health Risk |
Likely pathogenic |
Microcephaly-intellectual disability-sensorineural hearing loss-epilepsy-abnormal muscle tone syndrome, Microcephaly-intellectual disability-sensorineural hearing loss-epilepsy-abnormal muscle tone syndrome |
| RS1553970289 |
INTU
|
Health Risk |
Pathogenic/Likely pathogenic |
Orofaciodigital syndrome 17, Mohr syndrome |
| RS1553971826 |
ZEB2
|
Health Risk |
Pathogenic |
Mowat-Wilson syndrome, Mowat-Wilson syndrome |
| RS1553972275 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS1553974835 |
HAND2
|
Health Risk |
Pathogenic |
Dilated cardiomyopathy 1A, Dilated cardiomyopathy 1A |
| RS1553983416 |
NEB
|
Health Risk |
Likely pathogenic |
Nemaline myopathy 2, Nemaline myopathy 2 |
| RS1553983667 |
AFG2A
|
Health Risk |
Pathogenic/Likely pathogenic |
Microcephaly-intellectual disability-sensorineural hearing loss-epilepsy-abnormal muscle tone syndrome, Microcephaly-intellectual disability-sensorineural hearing loss-epilepsy-abnormal muscle tone syndrome |
| RS1553983844 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS1553986374 |
NR3C2
|
Health Risk |
Likely pathogenic |
Autosomal dominant pseudohypoaldosteronism type 1, Autosomal dominant pseudohypoaldosteronism type 1 |
| RS1553986377 |
NR3C2
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal dominant pseudohypoaldosteronism type 1, NR3C2-related disorder |
| RS1553987591 |
TTN
|
Health Risk |
Likely pathogenic |
— |
| RS1553990438 |
NEB
|
Health Risk |
Likely pathogenic |
Nemaline myopathy 2, Nemaline myopathy 2 |
| RS1553990750 |
NR3C2
|
Health Risk |
Pathogenic |
Autosomal dominant pseudohypoaldosteronism type 1, Autosomal dominant pseudohypoaldosteronism type 1 |
| RS1553993921 |
AGA
|
Health Risk |
Likely pathogenic |
Aspartylglucosaminuria, Sarcoma |
| RS1553994755 |
AGA
|
Health Risk |
Likely pathogenic |
Aspartylglucosaminuria, Aspartylglucosaminuria |
| RS1553994812 |
AGA
|
Health Risk |
Likely pathogenic |
Aspartylglucosaminuria, Aspartylglucosaminuria |
| RS1553994814 |
NAA15
|
Health Risk |
Pathogenic |
Intellectual disability, autosomal dominant 50 |
| RS1553994830 |
AGA
|
Health Risk |
Pathogenic/Likely pathogenic |
Aspartylglucosaminuria, Aspartylglucosaminuria |
| RS1553994874 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS1553995241 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS1553995639 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS1553995945 |
OTULIN
|
Health Risk |
Likely pathogenic |
— |
| RS1553996072 |
NAA15
|
Health Risk |
Pathogenic |
Intellectual disability, autosomal dominant 50 |
| RS1553996086 |
NAA15
|
Health Risk |
Pathogenic |
Intellectual disability, autosomal dominant 50 |
| RS1553996145 |
LRBA
|
Health Risk |
Likely pathogenic |
— |
| RS1553996375 |
SDHA
|
Health Risk |
Conflicting classifications of pathogenicity |
Mitochondrial complex II deficiency, nuclear type 1 |
| RS1553996876 |
NAA15
|
Health Risk |
Likely pathogenic |
Inborn genetic diseases, Neurodevelopmental disorder |
| RS1553997065 |
NAA15
|
Health Risk |
Pathogenic |
Intellectual disability, autosomal dominant 50 |
| RS1553997323 |
SDHA
|
Health Risk |
Pathogenic/Likely pathogenic |
Pheochromocytoma/paraganglioma syndrome 5, Mitochondrial complex II deficiency |
| RS1553997340 |
SDHA
|
Health Risk |
Likely pathogenic |
Pheochromocytoma/paraganglioma syndrome 5, Pheochromocytoma/paraganglioma syndrome 5 |
| RS1553997365 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive limb-girdle muscular dystrophy type 2J, Dilated cardiomyopathy 1G |
| RS1553997377 |
SDHA
|
Health Risk |
Likely pathogenic |
Mitochondrial complex II deficiency, nuclear type 1 |
| RS1553997617 |
SDHA
|
Health Risk |
Pathogenic/Likely pathogenic |
Mitochondrial complex II deficiency, nuclear type 1 |
| RS1553997826 |
SDHA
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1553998199 |
SDHA
|
Health Risk |
Pathogenic/Likely pathogenic |
Mitochondrial complex II deficiency, nuclear type 1 |
| RS1553998229 |
SDHA
|
Health Risk |
Pathogenic |
Mitochondrial complex II deficiency, nuclear type 1 |